Citadel Advisors
ENZ

Citadel Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Citadel Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,100
Closed -$16.9K – 15441
2023
Q3 		$16.9K Sell
12,100
-400
-3% -$603 ﹤0.01% 12754
2023
Q2 		$23K Sell
12,500
-26,700
-68% -$61.8K ﹤0.01% 12613
2023
Q1 		$95.3K Sell
39,200
-21,800
-36% -$32.4K ﹤0.01% 11335
2022
Q4 		$87.2K Buy
61,000
+29,300
+92% +$57.1K ﹤0.01% 11402
2022
Q3 		$71K Buy
+31,700
New +$76.6K ﹤0.01% 11375
2022
Q1 		– Sell
-21,600
Closed -$69K – 14777
2021
Q4 		$69K Sell
21,600
-33,200
-61% -$113K ﹤0.01% 13043
2021
Q3 		$194K Sell
54,800
-700
-1% -$2.33K ﹤0.01% 12029
2021
Q2 		$176K Sell
55,500
-13,300
-19% -$41.8K ﹤0.01% 12316
2021
Q1 		$237K Buy
68,800
+31,100
+82% +$96.7K ﹤0.01% 11367
2020
Q4 		$95K Buy
37,700
+23,600
+167% +$51.4K ﹤0.01% 10252
2020
Q3 		$30K Sell
14,100
-6,200
-31% -$14.7K ﹤0.01% 9762
2020
Q2 		$45K Buy
20,300
+3,200
+19% +$8.23K ﹤0.01% 9350
2020
Q1 		$43K Buy
+17,100
New +$42K ﹤0.01% 9097
2016
Q2 		– Sell
-14,700
Closed -$67K – 7514
2016
Q1 		$67K Buy
14,700
+100
+0.7% +$445 ﹤0.01% 6174
2015
Q4 		$66K Buy
14,600
+500
+4% +$2.11K ﹤0.01% 7085
2015
Q3 		$45K Buy
14,100
+8,100
+135% +$24.6K ﹤0.01% 7657
2015
Q2 		$18K Buy
6,000
+1,600
+36% +$4.5K ﹤0.01% 8210
2015
Q1 		$13K Buy
4,400
+3,900
+780% +$12.8K ﹤0.01% 8129
2014
Q4 		$2K Sell
500
-2,900
-85% -$13.8K ﹤0.01% 8378
2014
Q3 		$18K Hold
3,400
– – ﹤0.01% 7528
2014
Q2 		$18K Sell
3,400
-6,100
-64% -$26.4K ﹤0.01% 7353
2014
Q1 		$40K Sell
9,500
-6,600
-41% -$22.6K ﹤0.01% 6918
2013
Q4 		$47K Buy
16,100
+5,300
+49% +$13.1K ﹤0.01% 6081
2013
Q3 		$27K Buy
10,800
+100
+0.9% +$237 ﹤0.01% 6078
2013
Q2 		$22K Buy
+10,700
New +$23.6K ﹤0.01% 6032

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Citadel Advisors's ENZ Position: Q2 2025 in Review

Citadel Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 210,877 shares — an estimated $78K sold.

Citadel Advisors first reported a position in ENZ in Q2 2013 and held it in 44 quarters. The position peaked at $958K in Q4 2014. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Citadel Advisors reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 210,877 Enzo Biochem, Inc. shares in Q2 2025, an estimated $78K.
  • Citadel Advisors first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 44 quarters.
  • Citadel Advisors's Enzo Biochem, Inc. position peaked at $958K in Q4 2014.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.